Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |